Owner Cragmont Pharmaceuticals, LLC

Inventors Wei, Edward T.

Agent Fisher Adams Kelly

Pub. Number AU-B-2003222990

PCT Number PCT/GB03/01811

PCT Pub. Number WO2003/092697

Priority 10/267,896 08.10.02 US; 10/232,798 29.08.02 US; 10/233,126 29.08.02 US; 10/191,481 08.07.02 US; 10/139,193 02.05.02 US

Filing date 28 April 2003

Wipo publication date 17 November 2003

Acceptance publication date 12 November 2009

C07D 239/22 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61J 1/03 (2006.01) Containers specially adapted for medical or pharmaceutical purposes

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61M 35/00 (2006.01) Devices for applying media, e.g. remedies, on the human body

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/02 (2006.01) Medicinal preparations characterised by special physical form - Suppositories

A61M 15/08 (2006.01) Inhaling devices - Inhaling devices inserted into the nose